CytoMed Therapeutics Limited Ordinary Shares Share Price
NASDAQ: GDTCHealthcare
Live CytoMed Therapeutics Limited Ordinary Shares Share Price Chart
O H L
CytoMed Therapeutics Limited Ordinary Shares Performance Overview
Days Range
▼
$0.80Low
$0.85High
Markets Today
| Previous Close | $0.89 |
|---|---|
| Open | $0.85 |
| Volume | 20,101 |
| Day's Range | $0.80 - $0.85 |
| 52W Range | $0.68 - $3.68 |
| Market Cap | $10.48 M |
Historical Performance
| 1M Returns | -5.70 |
|---|---|
| 3M Returns | -17.96 |
| 6M Returns | -15.63 |
| 1Y Returns | -52.87 |
| 5Y Returns | NA |
| 10Y Returns | NA |
CytoMed Therapeutics Limited Ordinary Shares Fundamentals
| Market Cap | $10.48 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $252.12 K |
| ROE TTM | -0.51 |
| EPS TTM | $-0.27 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.05 |
| EBITDA | $-2.88 M |
| Profit Margin | -1231.97 |
| Market Cap | $10.48 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $252.12 K |
| ROE TTM | -0.51 |
| EPS TTM | $-0.27 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.05 |
| EBITDA | $-2.88 M |
| Profit Margin | -1231.97 |
CytoMed Therapeutics Limited Ordinary Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
CytoMed Therapeutics Limited Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| Share Capital | $17.98 M | $17.50 M | $19.16 M |
| Reserve & Surplus | -$9.35 M | -$10.92 M | -$14.63 M |
| Non-Current Liabilities | $309.03 K | $307.00 K | $328.07 K |
| Current Liabilities | $543.33 K | $446.24 K | $551.17 K |
| Total Liabilities | $852.36 K | $753.24 K | $879.24 K |
| Fixed Assets | $1.57 M | $2.46 M | $2.97 M |
| Current Assets | $7.65 M | $4.41 M | $2.85 M |
| Total Assets | $9.37 M | $7.41 M | $6.21 M |
CytoMed Therapeutics Limited Ordinary Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
CytoMed Therapeutics Limited Ordinary Shares Return Calculator
The CytoMed Therapeutics Limited Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About CytoMed Therapeutics Limited Ordinary Shares
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Popular Stocks
FAQs
What is the share price of CytoMed Therapeutics Limited Ordinary Shares today?
CytoMed Therapeutics Limited Ordinary Shares (GDTC) share price as of September 18, 2026 is $0.80. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of CytoMed Therapeutics Limited Ordinary Shares?
Yes, Indian Investors can invest in the CytoMed Therapeutics Limited Ordinary Shares (GDTC) Share by opening an international trading account with Angel One.
How can I purchase CytoMed Therapeutics Limited Ordinary Shares shares in India?
Purchasing CytoMed Therapeutics Limited Ordinary Shares (GDTC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying CytoMed Therapeutics Limited Ordinary Shares (GDTC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of CytoMed Therapeutics Limited Ordinary Shares?
Yes, you can purchase fractional shares of CytoMed Therapeutics Limited Ordinary Shares (GDTC) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of CytoMed Therapeutics Limited Ordinary Shares?
The market capitalization of CytoMed Therapeutics Limited Ordinary Shares on September 18, 2026, is $10.48 M.
In which sector CytoMed Therapeutics Limited Ordinary Shares belongs?
CytoMed Therapeutics Limited Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in CytoMed Therapeutics Limited Ordinary Shares stocks?
In order to invest in CytoMed Therapeutics Limited Ordinary Shares (GDTC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
